33
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Spatio-temporal and healthcare trends of non-endemic, invasive fungal infections in the United States, National Hospital Discharge Survey – 1996 to 2006

Pages 449-457 | Received 28 Jul 2009, Accepted 16 Aug 2009, Published online: 14 Oct 2009

References

  • Chamilos G, Luna M, Lewis RE, . Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91:986–989.
  • Horn DL, Fishman JA, Steinbach WJ, . Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. Diagn Microbiol Infect Dis 2007; 59:407–414.
  • Antinori S, Nebuloni M, Magni C, . Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol 2009; 132:221–227.
  • McNeil MM, Nash SL, Hajjeh RA, . Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001; 33:641–647.
  • Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20:133–163.
  • Wilson LS, Reyes CM, Stolpman M, . The direct cost and incidence of systemic fungal infections. Value Health 2002; 5:26–34.
  • Dasbach EJ, Davies GM, Teutsch SM. Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis 2000; 31:1524–1528.
  • MacDougall L, Kidd SE, Galanis E, . Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 2007; 13:42–50.
  • Upton A, Fraser JA, Kidd SE, . First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak. J Clin Microbiol 2007; 45:3086–3088.
  • Datta K, Bartlett KH, Marr KA. Cryptococcus gattii: emergence in western North America: Exploitation of a novel ecological niche. Interdiscip Perspect Infect Dis 2009; 15:1185–1191.
  • Byrnes Iii EJ, Bildfell RJ, Frank SA, . Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis 2009; 199:1081–1086.
  • Cuenca-Estrella M, Bernal-Martinez L, Buitrago MJ, . Update on the epidemiology and diagnosis of invasive fungal infection. Int J Antimicrob Agents 2008; 32(Suppl. 2):S143–147.
  • Cornely OA. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection 2008; 36:296–313.
  • U.S. Census (Available at: http://www.census.gov/econ/census07/www/geography/012144.html). Accessed 26 July 2009.
  • National Healthcare Disparities Report, 2006. Full Report. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/nhdr06/report/. Accessed 25 July 2009.
  • NCHS: National Hospital Discharge Survey (NHDS). Available at: http://www.cdc.gov/nchs/about/major/hdasd/nhds.htm. Accessed 26 March 2009.
  • Hosmer DW, Lemeshow S. Goodness-of-fit tests for the multiple logistic regression model. Comm Statist Theory Meth 1980; vA9:1043–1069.
  • Allison PD. Discrete-time methods for the analysis of event histories. Leinhardt S. Sociological Methods and Research, 15th. San Francisco, CA: Jossey-Bass, 1982.61–98.
  • Lawless JF. Survival Models and Methods for Lifetime Data New York: John Wiley & Sons, Inc., 1982.
  • Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546–1554.
  • Segal BH, Bow EJ, Menichetti F. Fungal infections in nontransplant patients with hematologic malignancies. Infect Dis Clin North Am 2002; 16:935–964.vii
  • Husain S, Alexander BD, Munoz P, . Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37:221–229.
  • Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transpl Int 2007; 20:993–1015.
  • Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32:358–366.
  • Neofytos D, Horn D, Anaissie E, . Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48:265–273.
  • Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48:1695–1703.
  • Dowell SF. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg Infect Dis 2001; 7:369–374.
  • Singh N, Wagener MM, Gayowski T. Seasonal pattern of early mortality and infectious complications in liver transplant recipients. Liver Transpl 2001; 7:884–889.
  • Park BJ, Sigel K, Vaz V, . An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J Infect Dis 2005; 191:1981–1987.
  • Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995; 95(Pt 1):955–961.
  • Port A, Hein J, Wolff A, Bielory L. Aeroallergen prevalence in the northern New Jersey-New York City metropolitan area: a 15-year summary. Ann Allergy Asthma Immunol 2006; 96:687–691.
  • Edi-Osagie NE, Emmerson AJ. Seasonality of invasive Candida infection in neonates. Acta Paediatr 2005; 94:72–74.
  • Chang DC, Burwell LA, Lyon GM, . Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. Infect Control Hosp Epidemiol 2008; 29:25–30.
  • Ascioglu S, Rex JH, de Pauw B, . Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7–14.
  • Borlenghi E, Cattaneo C, Capucci MA, . Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates. Ann Hematol 2007; 86:205–210.
  • Subira M, Martino R, Rovira M, . Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003; 82:80–82.
  • Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008; 47:1041–1050.
  • Benet T, Nicolle MC, Thiebaut A, . Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Clin Infect Dis 2007; 45:682–686.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.